Cingulate Inc. Note Agreements
11 Contracts & Agreements
- Note Conversion Agreement, dated January 25, 2024, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on January 29, 2024)
- Note Conversion Agreement, dated September 8, 2023, by and between the Company, Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on September 11, 2023)
- Amended and Restated Promissory Note, dated May 9, 2023, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on May 10, 2023)
- Promissory Note, dated August 9, 2022, between Cingulate Therapeutics, LLC and Werth Family Investment Associates LLC (Filed With SEC on August 11, 2022)
- Amendment to Note, dated May 20, 2021, between Dresch Inc. and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated February 1, 2020, between Dresch Inc. and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Amendment to Note, dated April 19, 2021, between Raul Silva and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated July 25, 2020, between Raul Silva and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Amendment to Notes, dated April 28, 2021, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated September 30, 2020, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
- Promissory Note, dated February 26, 2020, between Matthew Brams and Cingulate Therapeutics, LLC (Filed With SEC on September 9, 2021)
